Biomed Central Ltd

SHERPA: Unknown

People

  1. Park
    Park
  2. Chandra
    Chandra
  3. Dahi
    Dahi
  4. Guasp Baratech
    Guasp Baratech
  5. Imber
    Imber
  6. Odgerel
    Odgerel
  7. Rojas Exposito
    Rojas Exposito
  8. Scordo
    Scordo
  9. Soares
    Soares
  10. Yu
    Yu

Groups

  1. CTCR Scholars (16)
  2. MSK Grad Students (16)
  3. Master of Science in Clinical and Translational Cancer Research (16)
  4. Department of Medicine (14)
  5. Center for Pancreatic Cancer Research (11)
  6. Solid Tumor Oncology Division (10)
  7. Gastrointestinal Oncology Service (9)
  8. Sloan Kettering Institute Postdocs (7)
  9. Center for Hematologic Malignancies (4)
  10. Hematologic Malignancies, Division of (4)
Search Within
  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (9)
  2. Journal Article (4)
  3. Review (3)
Groups
  1. CTCR Scholars (16)
  2. MSK Grad Students (16)
  3. Master of Science in Clinical and Translational Cancer Research (16)
  4. Department of Medicine (14)
  5. Center for Pancreatic Cancer Research (11)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Wungki Park (9)
  2. Abderezak Zebboudj (2)
  3. Adrienne Chandra (2)
  4. Brandon Imber (2)
  5. Kevin Soares (2)
  6. Luis Rojas Exposito (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (12)
  2. Journal of Hematology & Oncology (3)
  3. Breast Cancer Research (1)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
    Journal Article

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Norton, C.; Tan, A. C.; Sokol, E. S.; Frampton, G.; Soares, H. P.; Puri, S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Gut dysbiosis suppresses anti-tumor ILC2S in pancreatic cancer
    Meeting Abstract

    Zebboudj, A.; Amisaki, M.; Guasp, P.; Rojas, L.; Sethna, Z.; Theresa, W.; Chandra, A.; Yu, R.; Odgerel, Z.; Soares, K.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Generalizability of predictive versus prognostic indicators from published transcriptomic associations with tumor response to immune checkpoint inhibition
    Meeting Abstract

    Bortone, D.; Monette, A.; Tschernia, N.; Cogdill, A.; Najjar, Y.; Sweis, R. F.; Valpione, S.; Wennerberg, E.; Bommareddy, P.; Haymaker, C.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection
    Journal Article

    Eroglu, Z.; Broman, K. K.; Thompson, J. F.; Nijhuis, A.; Hieken, T. J.; Kottschade, L.; Farma, J. M.; Hotz, M.; Deneve, J.; Fleming, M.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • High quality neoantigens are immunoedited in long-term pancreatic cancer survivors
    Meeting Abstract

    Sethna, Z.; Luksza, M.; Rojas, L.; Soares, K.; Leung, J.; Lihm, J.; Hoyos, D.; Dobrin, A.; Kappagantula, R.; Makohon-Moore, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: State of the art and future directions
    Review

    Ferraro, E.; Drago, J. Z.; Modi, S.
    Breast Cancer Research (2021)

    Fulltext@MSK | Save
  • How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
    Review

    Lumish, M.; Falchi, L.; Imber, B. S.; Scordo, M.; von Keudell, G.; Joffe, E.
    Journal of Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    Messersmith, W.; Rasco, D.; De Bono, J.; Wang-Gillam, A.; Park, W.; Nickle, D.; Galkin, A.; Ferguson, B.; Carter, L.; Zhou, L.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Preliminary results from Keynote-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors
    Meeting Abstract

    Bendell, J.; Messersmith, W.; Rasco, D.; Wang-Gillam, A.; Park, W.; Zhou, L.; Carter, L.; Bruey, J. M.; Li, J.; Ferguson, B.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save